Concepedia

Juan Carlos Rodrı́guez-Manzaneque

JC

Statistics

Publications

34

Citations

3.1K

H-Index

25

Active since

1994

Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research(Current)

Universidad de Granada

University of California, Los Angeles

Institució Catalana de Recerca i Estudis Avançats

Universitat de Barcelona

Juan Carlos Rodrı́guez-Manzaneque is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1994–2024

34

Publications

34

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

Juan Carlos Rodrı́guez-Manzaneque, Timothy F. Lane, Maria-Asunción Ortega et al. · Proceedings of the National Academy of Sciences · 2001 · 467 citations · Full text

, , +17

Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4

John D. Sandy, Jennifer Westling, Richard D. Kenagy et al. · Journal of Biological Chemistry · 2001 · 457 citations · Full text

, , +13

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

Juan Carlos Rodríguez‐Manzaneque, Jennifer Westling, Shelley N.-M. Thai et al. · Biochemical and Biophysical Research Communications · 2002 · 234 citations

, , +8

Characterization of METH-1/ADAMTS1 Processing Reveals Two Distinct Active Forms

Juan Carlos Rodrı́guez-Manzaneque, Allison B. Milchanowski, Erick K. Dufour et al. · Journal of Biological Chemistry · 2000 · 150 citations · Full text

, , +9

Progesterone Regulates Proliferation of Endothelial Cells

Francisca Vázquez, Juan Carlos Rodríguez‐Manzaneque, John P. Lydon et al. · Journal of Biological Chemistry · 1999 · 143 citations · Full text

, , +12

1–5 of 34